Tget 0.003 belongs to the generic category of Gatifloxacin. This medicine should be used according to a doctor's advice. We have provided detailed information about the uses, dosage, effectiveness, side effects, precautions, drug interactions, storage conditions, and other important details of Tget 0.003. Our goal is to present essential medicine information in one place for patients, caregivers, and healthcare professionals. To better understand Gatifloxacin and ensure the safe use of this medicine, please read the information below carefully and consult a healthcare professional when necessary.

/ 5 ml drop
Tget 0.003 may be available as a prescription or over-the-counter medicine, depending on local regulations and medical recommendations. It is used for the treatment and management of specific conditions or symptoms. The way this medicine is used may vary depending on the patient's condition and the advice of a healthcare provider. Detailed information about the approved uses, therapeutic applications, and other relevant details of Tget 0.003 is provided below to help users gain a clear understanding of this medicine.
Gatifloxacin eye drops is indicated for the treatment of bacterial conjunctivitis caused by susceptible strains of the following organisms:Aerobic Gram-Positive Bacteria:
Corynebacterium propinquum
Staphylococcus aureus
Staphylococcus epidermidis
Streptococcus mitis
Streptococcus pneumoniae
Aerobic Gram-Negative Bacteria:
Haemophilus influenzae.
Gatifloxacin eye drops is an 8-methoxyfluoroquinolone anti-infective for topical ophthalmic use. The antibacterial action of Gatifloxacin results from inhibition of DNA gyrase and topoisomerase IV. DNA gyrase is an essential enzyme that is involved in the replication, transcription and repair of bacterial DNA. Topoisomerase IV is an enzyme known to play a key role in the partitioning of the chromosomal DNA during bacterial cell division. It appears that the C-8-methoxy moiety contributes to enhanced activity and lower selection of resistant mutants of gram-positive bacteria compared to the nonmethoxy C-8 moiety.
Gatifloxacin 0.3%: The recommended dosage regimen for the treatment of bacterial conjunctivitis is:
Days 1 and 2: Instill one drop every two hours in the affected eye(s) while awake, up to 8 times daily.
Days 3 through 7: Instill one drop up to 4 times daily while awake.
Gatifloxacin 0.5%: Patients 1 year of age or older:
Day 1: Instill one drop every two hours in the affected eye(s) while awake, up to 8 times.
Days 2 through 7: Instill one drop two to four times daily in the affected eye(s) while awake.
Specific drug interaction studies have not been conducted with Gatifloxacin eye drops.
The most frequently reported adverse events in the overall study population were conjunctival irritation, increased lacrimation etc.
Because there are no adequate and well-controlled studies in pregnant women, Gatifloxacin eye drops should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. It is not known whether this drug is excreted in human milk. Because many drugs are excreted in human milk, caution should be exercised when Gatifloxacin is administered to a nursing woman.
Patients should be advised not to wear contact lenses if they have signs and symptoms of bacterial conjunctivitis. Avoid contaminating the applicator tip with material from the eye, fingers or other source.
Ophthalmic antibacterial drugs
Protect from light. Store in cool & dry place; keep out of the reach of children. Do not use more than 4 weeks after opening.
Data Source: Data source of Indications and Usages, Pharmacology, Dosage & Administration, Drug Interactions, Side Effects, Use during Pregnancy & Lactation, Precautions & Warnings, Use in Special Populations, Therapeutic Class, and Storage Conditions is the concerned medicine company or respective organization.
The information provided on All Samadhan is intended for general informational purposes only and is prepared based on our best practices. It is not a substitute for professional medical advice, diagnosis, or treatment. While we strive to keep the information accurate and up to date, we do not guarantee its completeness or accuracy. The absence of specific information or warnings about any medicine or service should not be considered as an assurance or endorsement by All Samadhan. All Samadhan shall not be held responsible for any consequences arising from the use of this information. We strongly recommend consulting a qualified healthcare professional or physician for any medical concerns, questions, or clarifications.All Samadhan is a digital healthcare software platform operated by MS Genius Experts. We provide technology solutions for pharmacies and healthcare providers; we are not a direct seller or dispenser of prescription medicines

N:B-All Samadhan is a digital healthcare software platform operated by MS Genius Experts. We provide technology solutions for pharmacies and healthcare providers; we are not a direct seller or dispenser of prescription medicines"
Copyright © All Samadhan - Operated by M/S. Genius Experts | All Rights Reserved
DBID
Registration ID: 176322642
Trade License: TRAD/DNCC/040904/2023